-
Mutual Funds
-
Insurance
-
Calculators
Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
Compare Mutual Funds
Comparing ITI Pharma and Healthcare Fund vs Tata India Pharma & HealthCare FundComparing 2/4 funds
- Add Fund
- Add Fund
- Category,
Sub-category - equity, sectoral-pharma
- equity, sectoral-pharma
- Fund Age
- 3 yrs 9 m
- 9 yrs 7 m
- Fund Size
- ₹221 Cr
- ₹1,232 Cr
- 3 months
- 13.51%
- 13.04%
- 6 months
- -2.81%
- -1.8%
- 1 year
- 16.32%
- 14.52%
- 3 year
- 26.7%
- 27.21%
- 5 year
- NA
- 24.23%
- Standard Deviation
- 15.46
- 15.95
- Sharpe
- 1.2
- 1.2
- Beta
- 0.95
- 0.99
- Sortino
- 1.67
- 1.83
- Alpha
- -0.16
- -0.37
- Top 3 sectors
- Healthcare (93.84%)
- Chemicals (3.6399999999999997%)
- Services (1.29%)
- Healthcare (87.23000000000002%)
- Services (2.19%)
- Chemicals (1.4100000000000001%)
- Top 5 holdings
- Sun Pharmaceutical Industries Ltd. (15.18%)
- Divi's Laboratories Ltd. (9.12%)
- Max Healthcare Institute Ltd. (5.42%)
- Lupin Ltd. (5.4%)
- Apollo Hospitals Enterprise Ltd. (5.19%)
- Sun Pharmaceutical Industries Ltd. (11.64%)
- Apollo Hospitals Enterprise Ltd. (6.22%)
- Cipla Ltd. (5.83%)
- Aurobindo Pharma Ltd. (5.73%)
- Divi's Laboratories Ltd. (5.63%)
- Equity%
- 99.7%
- 90.83%
- Debt%
- 0.0%
- 0.0%
- Turnover Ratio
- NA
- NA
- Yield To Maturity
- NA
- NA
- Modified Duration
- NA
- NA
- Avg. Maturity
- NA
- NA
- Avg. Credit Quality
- NA
- NA
- Expense Ratio
- 0.47%
- 0.63%
- Exit Load
- 0.5% know more
- 0.25% know more
- Lock-in
- No Lockin
- No Lockin
- Benchmark Index
- NIFTY Healthcare TRI.
- NIFTY Pharma TRI
- Min. Investment
- NA
- SIP ₹500 & Lumpsum ₹5000
- Investment Horizon
- Good for Long Term
- Good for Long Term
- Managed By
- Rohan Korde
- Dhimant Shah
- Meeta Shetty
- Rajat Srivastava
